文献速递遗传性与小管间质肾病

304例常染色体隐性多囊肾病患者PKHD1基因变异与表型关联的细化研究

Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants.
PubMed 文献 · Kidney Int · 2021-04-30

该观察性研究分析两个独立队列共304例ARPKD患者的深度临床数据,识别儿童期和青春期新的基因型-表型关联。双等位基因无效变异常表现为严重病程;影响纤维囊蛋白不同氨基酸区域的错义变异与慢性肾衰竭及肝脏结局相关。研究扩展了对儿科ARPKD基因型-表型关联的理解,为更精准的咨询和治疗奠定基础。

要点

  • 双等位基因无效变异在ARPKD中常表现为严重病程。
  • 影响纤维囊蛋白709-1837区域的错义变异与较少发生慢性肾衰竭相关。
  • 影响1838-2624区域的错义变异肝脏结局较好,而2625-4074区域与较差肝脏结局相关。

核心结论

  • ARPKD的基因型-表型关联不仅限于双等位基因无效变异与最严重表型的关联,变异所在PKHD1区域也影响表型。

研究设计与样本

  • 观察性研究,分析来自两个独立队列的304例ARPKD患者的深度临床数据集。

主要发现

  • 双等位基因无效变异常表现为严重病程。
  • 携带两个影响纤维囊蛋白709-1837氨基酸区域的错义变异,或该区域错义变异与无效变异的患者,较少发生慢性肾衰竭。
  • 影响纤维囊蛋白1838-2624氨基酸区域的错义变异患者肝脏结局较好。
  • 影响纤维囊蛋白2625-4074氨基酸区域的变异与较差的肝脏结局相关。

临床怎么用

  • 研究结果可用于儿科ARPKD患者更精准和个性化的咨询与治疗决策。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autosomal recessive polycystic kidney disease (ARPKD) is a severe disease of early childhood that is clinically characterized by fibrocystic changes of the kidneys and the liver. The main cause of ARPKD are variants in the PKHD1 gene encoding the large transmembrane protein fibrocystin. The mechanisms underlying the observed clinical heterogeneity in ARPKD remain incompletely understood, partly due to the fact that genotype-phenotype correlations have been limited to the association of biallelic null variants in PKHD1 with the most severe phenotypes. In this observational study we analyzed a deep clinical dataset of 304 patients with ARPKD from two independent cohorts and identified novel genotype-phenotype correlations during childhood and adolescence. Biallelic null variants frequently show severe courses. Additionally, our data suggest that the affected region in PKHD1 is important in determining the phenotype. Patients with two missense variants affecting amino acids 709-1837 of fibrocystin or a missense variant in this region and a null variant less frequently developed chronic kidney failure, and patients with missense variants affecting amino acids 1838-2624 showed better hepatic outcome. Variants affecting amino acids 2625-4074 of fibrocystin were associated with poorer hepatic outcome. Thus, our data expand the understanding of genotype-phenotype correlations in pediatric ARPKD patients and can lay the foundation for more precise and personalized counselling and treatment approaches.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Burgmaier K, Brinker L, Erger F, et al. Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants. Kidney Int. 2021. PMID: 33940108. doi:10.1016/j.kint.2021.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。